ArticleNature communications2026
Rank-guided learning accelerates automated enzyme engineering.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rank-guided learning accelerates automated enzyme engineering.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enzyme catalysis has become a cornerstone of modern synthesis, offering sustainable routes to structurally complex molecules. However, the rugged fitness landscape and limited model capacity to learn from sparse data constrain the development of biocatalysts. Here, we present Rank-guided Exploration for Automated enzyme reProgramming (REAP), a closed-loop platform that combines artificial intelligence with robotic experimentation to accelerate enzyme engineering. At its core, REAP is powered by RankReg, a hybrid loss function that jointly optimizes ranking fidelity and quantitative accuracy, enabling adaptive in-loop learning directly from experimental feedback. This ranking-regression framework allows REAP to identify functional hotspots across both catalytic centers and previously underexplored distal regions, and to progressively extend model-guided exploration from single mutations to productive combinatorial variants. Applied to cytochrome P450 BM3, REAP achieved a 57-fold improvement in desired activity within five cycles, and further produced up to 104-fold enhancement in Staphylococcus aureus Sortase A (SaSrtA). By coupling algorithmic innovation with automation, REAP establishes a scalable and generalizable framework for accelerating biocatalyst discovery and expanding the scope of enzyme-enabled synthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.